Adalimumab

• Description :

  Adalimumab anti-TNF-alpha) is the first fully human recombinant IgG1 monoclonal antibody that specifically targets human TNF-alpha.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  148 kDa

• Molecular Formula :

  ——

• Notes :

  Research use only, not for human use.

• Receptor :

  TNF

• CAS Number :

  331731-18-1